Passive Transfer of Vaccine-Elicited Antibodies Protects against SIV in Rhesus Macaques. 2020

Galit Alter, and Wen-Han Yu, and Abishek Chandrashekar, and Erica N Borducchi, and Khader Ghneim, and Ashish Sharma, and Rebecca Nedellec, and Katherine R McKenney, and Caitlyn Linde, and Thomas Broge, and Todd J Suscovich, and Tom Linnekin, and Peter Abbink, and Noe B Mercado, and Joseph P Nkolola, and Katherine McMahan, and Esther A Bondzie, and Venous Hamza, and Lauren Peter, and Nicole Kordana, and Shant Mahrokhian, and Michael S Seaman, and Wenjun Li, and Mark G Lewis, and Douglas A Lauffenburger, and Lars Hangartner, and Rafick-Pierre Sekaly, and Dan H Barouch
Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA 02139, USA.

Several HIV-1 and SIV vaccine candidates have shown partial protection against viral challenges in rhesus macaques. However, the protective efficacy of vaccine-elicited polyclonal antibodies has not previously been demonstrated in adoptive transfer studies in nonhuman primates. In this study, we show that passive transfer of purified antibodies from vaccinated macaques can protect naive animals against SIVmac251 challenges. We vaccinated 30 rhesus macaques with Ad26-SIV Env/Gag/Pol and SIV Env gp140 protein vaccines and assessed the induction of antibody responses and a putative protective signature. This signature included multiple antibody functions and correlated with upregulation of interferon pathways in vaccinated animals. Adoptive transfer of purified immunoglobulin G (IgG) from the vaccinated animals with the most robust protective signatures provided partial protection against SIVmac251 challenges in naive recipient rhesus macaques. These data demonstrate the protective efficacy of purified vaccine-elicited antiviral antibodies in this model, even in the absence of virus neutralization.

UI MeSH Term Description Entries
D007074 Immunoglobulin G The major immunoglobulin isotype class in normal human serum. There are several isotype subclasses of IgG, for example, IgG1, IgG2A, and IgG2B. Gamma Globulin, 7S,IgG,IgG Antibody,Allerglobuline,IgG(T),IgG1,IgG2,IgG2A,IgG2B,IgG3,IgG4,Immunoglobulin GT,Polyglobin,7S Gamma Globulin,Antibody, IgG,GT, Immunoglobulin
D007116 Immunization, Passive Transfer of immunity from immunized to non-immune host by administration of serum antibodies, or transplantation of lymphocytes (ADOPTIVE TRANSFER). Convalescent Plasma Therapy,Immunoglobulin Therapy,Immunotherapy, Passive,Normal Serum Globulin Therapy,Passive Antibody Transfer,Passive Transfer of Immunity,Serotherapy,Passive Immunotherapy,Therapy, Immunoglobulin,Antibody Transfer, Passive,Passive Immunization,Therapy, Convalescent Plasma,Transfer, Passive Antibody
D008253 Macaca mulatta A species of the genus MACACA inhabiting India, China, and other parts of Asia. The species is used extensively in biomedical research and adapts very well to living with humans. Chinese Rhesus Macaques,Macaca mulatta lasiota,Monkey, Rhesus,Rhesus Monkey,Rhesus Macaque,Chinese Rhesus Macaque,Macaca mulatta lasiotas,Macaque, Rhesus,Rhesus Macaque, Chinese,Rhesus Macaques,Rhesus Macaques, Chinese,Rhesus Monkeys
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000914 Antibodies, Viral Immunoglobulins produced in response to VIRAL ANTIGENS. Viral Antibodies
D000917 Antibody Formation The production of ANTIBODIES by proliferating and differentiated B-LYMPHOCYTES under stimulation by ANTIGENS. Antibody Production,Antibody Response,Antibody Responses,Formation, Antibody,Production, Antibody,Response, Antibody,Responses, Antibody
D015302 Simian Immunodeficiency Virus Species of the genus LENTIVIRUS, subgenus primate immunodeficiency viruses (IMMUNODEFICIENCY VIRUSES, PRIMATE), that induces acquired immunodeficiency syndrome in monkeys and apes (SAIDS). The genetic organization of SIV is virtually identical to HIV. SIV (Simian immunodeficiency virus),Immunodeficiency Viruses, Simian,Simian Immunodeficiency Viruses,Immunodeficiency Virus, Simian
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D015683 Gene Products, gag Proteins coded by the retroviral gag gene. The products are usually synthesized as protein precursors or POLYPROTEINS, which are then cleaved by viral proteases to yield the final products. Many of the final products are associated with the nucleoprotein core of the virion. gag is short for group-specific antigen. Viral gag Proteins,gag Antigen,gag Gene Product,gag Gene Products,gag Polyproteins,gag Protein,gag Viral Proteins,Gene Product, gag,Retroviral Antigen gag Protein,gag Antigens,gag Gene Related Protein,gag Polyprotein,Antigen, gag,Antigens, gag,Polyprotein, gag,Polyproteins, gag,Protein, gag,Proteins, Viral gag,Proteins, gag Viral,Viral Proteins, gag,gag Proteins, Viral
D015684 Gene Products, pol Retroviral proteins coded by the pol gene. They are usually synthesized as a protein precursor (POLYPROTEINS) and later cleaved into final products that include reverse transcriptase, endonuclease/integrase, and viral protease. Sometimes they are synthesized as a gag-pol fusion protein (FUSION PROTEINS, GAG-POL). Pol is short for polymerase, the enzyme class of reverse transcriptase. pol Gene Products,pol Polyproteins,pol Protein,Gene Product, pol,pol Polyprotein,Polyprotein, pol,Polyproteins, pol,Protein, pol,pol Gene Product

Related Publications

Galit Alter, and Wen-Han Yu, and Abishek Chandrashekar, and Erica N Borducchi, and Khader Ghneim, and Ashish Sharma, and Rebecca Nedellec, and Katherine R McKenney, and Caitlyn Linde, and Thomas Broge, and Todd J Suscovich, and Tom Linnekin, and Peter Abbink, and Noe B Mercado, and Joseph P Nkolola, and Katherine McMahan, and Esther A Bondzie, and Venous Hamza, and Lauren Peter, and Nicole Kordana, and Shant Mahrokhian, and Michael S Seaman, and Wenjun Li, and Mark G Lewis, and Douglas A Lauffenburger, and Lars Hangartner, and Rafick-Pierre Sekaly, and Dan H Barouch
July 1995, AIDS research and human retroviruses,
Galit Alter, and Wen-Han Yu, and Abishek Chandrashekar, and Erica N Borducchi, and Khader Ghneim, and Ashish Sharma, and Rebecca Nedellec, and Katherine R McKenney, and Caitlyn Linde, and Thomas Broge, and Todd J Suscovich, and Tom Linnekin, and Peter Abbink, and Noe B Mercado, and Joseph P Nkolola, and Katherine McMahan, and Esther A Bondzie, and Venous Hamza, and Lauren Peter, and Nicole Kordana, and Shant Mahrokhian, and Michael S Seaman, and Wenjun Li, and Mark G Lewis, and Douglas A Lauffenburger, and Lars Hangartner, and Rafick-Pierre Sekaly, and Dan H Barouch
January 1994, Journal of medical primatology,
Galit Alter, and Wen-Han Yu, and Abishek Chandrashekar, and Erica N Borducchi, and Khader Ghneim, and Ashish Sharma, and Rebecca Nedellec, and Katherine R McKenney, and Caitlyn Linde, and Thomas Broge, and Todd J Suscovich, and Tom Linnekin, and Peter Abbink, and Noe B Mercado, and Joseph P Nkolola, and Katherine McMahan, and Esther A Bondzie, and Venous Hamza, and Lauren Peter, and Nicole Kordana, and Shant Mahrokhian, and Michael S Seaman, and Wenjun Li, and Mark G Lewis, and Douglas A Lauffenburger, and Lars Hangartner, and Rafick-Pierre Sekaly, and Dan H Barouch
January 1995, AIDS (London, England),
Galit Alter, and Wen-Han Yu, and Abishek Chandrashekar, and Erica N Borducchi, and Khader Ghneim, and Ashish Sharma, and Rebecca Nedellec, and Katherine R McKenney, and Caitlyn Linde, and Thomas Broge, and Todd J Suscovich, and Tom Linnekin, and Peter Abbink, and Noe B Mercado, and Joseph P Nkolola, and Katherine McMahan, and Esther A Bondzie, and Venous Hamza, and Lauren Peter, and Nicole Kordana, and Shant Mahrokhian, and Michael S Seaman, and Wenjun Li, and Mark G Lewis, and Douglas A Lauffenburger, and Lars Hangartner, and Rafick-Pierre Sekaly, and Dan H Barouch
March 2015, Proceedings of the National Academy of Sciences of the United States of America,
Galit Alter, and Wen-Han Yu, and Abishek Chandrashekar, and Erica N Borducchi, and Khader Ghneim, and Ashish Sharma, and Rebecca Nedellec, and Katherine R McKenney, and Caitlyn Linde, and Thomas Broge, and Todd J Suscovich, and Tom Linnekin, and Peter Abbink, and Noe B Mercado, and Joseph P Nkolola, and Katherine McMahan, and Esther A Bondzie, and Venous Hamza, and Lauren Peter, and Nicole Kordana, and Shant Mahrokhian, and Michael S Seaman, and Wenjun Li, and Mark G Lewis, and Douglas A Lauffenburger, and Lars Hangartner, and Rafick-Pierre Sekaly, and Dan H Barouch
June 2020, Molecular therapy. Methods & clinical development,
Galit Alter, and Wen-Han Yu, and Abishek Chandrashekar, and Erica N Borducchi, and Khader Ghneim, and Ashish Sharma, and Rebecca Nedellec, and Katherine R McKenney, and Caitlyn Linde, and Thomas Broge, and Todd J Suscovich, and Tom Linnekin, and Peter Abbink, and Noe B Mercado, and Joseph P Nkolola, and Katherine McMahan, and Esther A Bondzie, and Venous Hamza, and Lauren Peter, and Nicole Kordana, and Shant Mahrokhian, and Michael S Seaman, and Wenjun Li, and Mark G Lewis, and Douglas A Lauffenburger, and Lars Hangartner, and Rafick-Pierre Sekaly, and Dan H Barouch
January 2000, Developments in biologicals,
Galit Alter, and Wen-Han Yu, and Abishek Chandrashekar, and Erica N Borducchi, and Khader Ghneim, and Ashish Sharma, and Rebecca Nedellec, and Katherine R McKenney, and Caitlyn Linde, and Thomas Broge, and Todd J Suscovich, and Tom Linnekin, and Peter Abbink, and Noe B Mercado, and Joseph P Nkolola, and Katherine McMahan, and Esther A Bondzie, and Venous Hamza, and Lauren Peter, and Nicole Kordana, and Shant Mahrokhian, and Michael S Seaman, and Wenjun Li, and Mark G Lewis, and Douglas A Lauffenburger, and Lars Hangartner, and Rafick-Pierre Sekaly, and Dan H Barouch
October 2023, Cell,
Galit Alter, and Wen-Han Yu, and Abishek Chandrashekar, and Erica N Borducchi, and Khader Ghneim, and Ashish Sharma, and Rebecca Nedellec, and Katherine R McKenney, and Caitlyn Linde, and Thomas Broge, and Todd J Suscovich, and Tom Linnekin, and Peter Abbink, and Noe B Mercado, and Joseph P Nkolola, and Katherine McMahan, and Esther A Bondzie, and Venous Hamza, and Lauren Peter, and Nicole Kordana, and Shant Mahrokhian, and Michael S Seaman, and Wenjun Li, and Mark G Lewis, and Douglas A Lauffenburger, and Lars Hangartner, and Rafick-Pierre Sekaly, and Dan H Barouch
March 2021, PLoS neglected tropical diseases,
Galit Alter, and Wen-Han Yu, and Abishek Chandrashekar, and Erica N Borducchi, and Khader Ghneim, and Ashish Sharma, and Rebecca Nedellec, and Katherine R McKenney, and Caitlyn Linde, and Thomas Broge, and Todd J Suscovich, and Tom Linnekin, and Peter Abbink, and Noe B Mercado, and Joseph P Nkolola, and Katherine McMahan, and Esther A Bondzie, and Venous Hamza, and Lauren Peter, and Nicole Kordana, and Shant Mahrokhian, and Michael S Seaman, and Wenjun Li, and Mark G Lewis, and Douglas A Lauffenburger, and Lars Hangartner, and Rafick-Pierre Sekaly, and Dan H Barouch
April 2011, Vaccine,
Galit Alter, and Wen-Han Yu, and Abishek Chandrashekar, and Erica N Borducchi, and Khader Ghneim, and Ashish Sharma, and Rebecca Nedellec, and Katherine R McKenney, and Caitlyn Linde, and Thomas Broge, and Todd J Suscovich, and Tom Linnekin, and Peter Abbink, and Noe B Mercado, and Joseph P Nkolola, and Katherine McMahan, and Esther A Bondzie, and Venous Hamza, and Lauren Peter, and Nicole Kordana, and Shant Mahrokhian, and Michael S Seaman, and Wenjun Li, and Mark G Lewis, and Douglas A Lauffenburger, and Lars Hangartner, and Rafick-Pierre Sekaly, and Dan H Barouch
December 2012, Cell reports,
Copied contents to your clipboard!